Mortality trends of gastrointestinal cancers in Iranian population

Gastroenterology and Hepatology from Bed to Bench

Volumn 6, Issue SUPPL., 2013, Pages

  Pourhoseingholi, Mohamad Amin ^a   Fazeli, Zeinab ^b   Ashtari, Sara ^a   Bavand Pour, Fatemeh Sadat Fazeli ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Colorectal cancer; Esophageal cancer; Gastric cancer; Hepatocellular carcinoma; Pancreas cancer

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER MORTALITY; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; ESOPHAGUS CANCER; FEMALE; GROUPS BY AGE AND SEX; HUMAN; ICD-9; IRAN; LIVER CELL CARCINOMA; MALE; PANCREAS CANCER; POPULATION RESEARCH; STOMACH CANCER;

EID: 84888794288     PISSN: 20082258     EISSN: 20084234     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Naghavi M, Editor. Death report from 23 provinces in Iran. 1st edition. Tehran: Ministry of Health and Medical Education; 2004. [In Persian]
2. Mosavi-Jarrahi A, Mohagheghi MA. Epidemiology of esophageal cancer in the high-risk population of Iran. Asian Pac J Cancer Prev 2006; 7: 375-80.
3. Pourhoseingholi MA, Vahedi M, Moghimi-Dehkordi B, Pourhoseingholi A, Ghafarnejad F, Maserat E, et al. Burden of hospitalization for gastrointestinal tract cancer patients - Results from a cross-sectional study in Tehran. Asian Pac J Cancer Prev 2009; 10:107-10.
4. Cancer incidence in the Tehran Metropolita. Second report of the Tehran population-based cancer registry. Tehran: The Cancer Institute, Cancer Research Centre; 2007.
5. Moghimi-Dehkordi B, Safaee A, Zali MR. Comparison of colorectal and gastric cancer: survival and prognostic factors. Saudi J Gastroenterol 2009; 15:18-23.
6. Parkin DM. International variation. Oncogene 2004; 23:6329-40.
7. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000: the global picture. Eur J Cancer 2001; 37:S4-S66.
8. Pourhoseingholi MA, Hajizadeh E, Moghimi Dehkordi B, Safaee A, Abadi A, Zali MR. Comparing Cox regression and parametric models for survival of patients with gastric carcinoma. Asian Pac J Cancer Prev 2007; 8:412-6.
9. Moghimi-Dehkordi B, Safaee A, Pourhoseingholi MA, Zali MR. Effect of demographic and clinicopathologic factors on prognosis of early gastric cancer in Iran. Asian Pac J Cancer Prev 2008; 9:585-8.
10. Pourhoseingholi MA, Moghimi-Dehkordi B, Safaee A, Hajizadeh E, Solhpur A, Zali MR. Prognostic factors in gastric cancer using log-normal censored regression model. Indian J Med Res 2009; 129:262-7.
11. Pourhoseingholi MA, Faghihzadeh S, Hajizadeh E, Gatta G, Zali MR, Abadi AR. Trend Analysis of Gastric Cancer and Colorectal Cancer Mortality in Iran, 1995-2003. Iran J Cancer Prev 2011; 1:38-43.
12. Pourhoseingholi MA, Faghihzadeh S, Hajizadeh E, Abadi A Bayesian Analysis of Gastric Cancer mortality in Iranian Population. Gastroenterol Hepatol Bed Bench 2010;3:15-18.
13. Sonnenberg A, Delcò F, Inadomi JM. Costeffectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 2000; 133:573-84.
14. World Health Organization. Cancer incidence in five continents. Lyon: IARC Press; IARC Scientific Publication; 2002.
15. Moghimi-Dehkordi B, Safaee A, Zali MR. Prognostic factors in 1,138 Iranian colorectal cancer patients. Int J Colorectal Dis 2008; 23:683-88.
16. Azadeh S, Moghimi-Dehkordi B, Fatemi SR, Pourhoseingholi MA, Ghiasi S, Zali MR. Colorectal cancer in Iran: an epidemiological study. Asian Pac J Cancer Prev 2008; 9:123-26.
17. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108.
18. Polednak AP. Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. Int J Cancer 2003;105: 98-100.
19. Pourhoseingholi MA, Fazeli Z, Zali MR, Alavian SM. Burden of Hepatocellular Carcinoma in Iran; Bayesian Projection and Trend Analysis Asian Pac J Cancer Prev 2010;11:859-62.
20. Lowenfels AB, Maisonneuve P. Risk factors for pancreatic cancer. J Cell Biochem 2005;95:649-56.
21. Iranian Annual of National Cancer Registration Report. Tehran: Ministry of Health and Medical Education, Center for Disease Control & Prevention, Noncommunicable Deputy, Cancer Office; 2008.
22. Burnet NG, Jefferies SJ, Benson RJ, Hunt DP, Treasure FP. Years of life lost (YLL) from cancer is an important measure of population burden--and should be considered when allocating research funds. Br J Cancer 2005;92:241-45.
23. Naghavi M, Editor. Death report from 18 provinces in Iran. 1st edition. Tehran, Iran: Ministry of Health and Medical Education; 2002. [In Persian]
24. Naghavi M, Editor. Death report from 18 provinces in Iran. 1st edition. Tehran, Iran: Ministry of Health and Medical Education; 2003. [In Persian]
25. National Statistics Center, Online Publications at: http://amar.sci.org.ir/PlanList.aspx.
26. Sadjadi A, Nouraie M, Mohagheghi MA, Mousavi-Jarrahi A, Malekzadeh R, Donald Maxwell P. Cancer occurrence in Iran in 2002, an international prospective. Asian Pacific J Cancer Prev 2005; 6:359-63.
27. Levi F, Lucchini F, La Vecchia C, Negri E. Trends in mortality from cancer in European Union, 1955-94. Lancet 1999; 354:742-43.
28. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C. Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960. Int J Cancer 2004; 110:155-69.
29. Moghimi-Dehkordi B, Safaee A, Zali MR. Survival rates and prognosis of gastric cancer using an actuarial life-table method. Asian Pac J Cancer Prev 2008; 9:317-21.
30. Fernandez E, La Vecchia C, Gonzalez JR, Lucchini F, Negri E, Levi F. Converging patterns of CR mortality in Europe. Eur J Cancer 2005; 41:430-37.
31. Valean S, Mircea PA, Oprea L, Frentiu D, Popescu G, Nagy G, et al. Trends of mortality rates from gastric cancer and colorectal cancer in Romania 1955-2003. J Gastrointestin Liver Dis 2006; 15:111-15.
32. Annual National Cancer Registration Report 2005-2006. Tehran, Iran: Iranian: Ministry of Health and Medical Education, Center for Disease Control and Prevention, Non-communicable Deputy Cancer Office; 2007. [In Persian]
33. Hosseini SV, Izadpanah A, Yarmohammadi H. Epidemiological changes in colorectal cancer in Shiraz, Iran: 1980-2000. ANZ J Surg 2004; 74:547-49.
34. Moradi A, Khayamzadeh M, Guya MM, Mirzaei HR, Salmanian R, Rakhsha A, Akbari ME. Survival of colorectal cancer in Iran. Asian Pac J Cancer Prev 2009; 10:583-86.
35. Malekzadeh R, Bishehsari F, Mahdavinia M, Ansari R. Epidemiology and molecular genetics of colorectal cancer in Iran: a review. Arch Iran Med 2009; 12:161-19.
36. Qiu D, Kaneko S. Comparison of esophageal cancer mortality in five countries: France, Italy, Japan, UK and USA from the WHO mortality database (1960-2000). Jpn J Clin Oncol 2005;35:564-67.
37. Ke L. Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970-Int J Cancer 2002; 102:271-4.
38. IARC: Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004;83:1-1438.
39. Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med 2004; 38:613-19.
40. Islami F, Kamangar F, Nasrollahzadeh D, Møller H, Boffetta P, Malekzadeh R. Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran - a review. Eur J Cancer 2009;45:3156-65.
41. Islami F, Kamangar F, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Abedi-Ardekani B, et al. Socio-economic status and oesophageal cancer: results from a populationbased case-control study in a high-risk area. Int J Epidemiol 2009;38:978-88.
42. Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, Shakeri R, et al. Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ 2009; 26;338:b929.
43. Hajiani E, Masjedizadeh R, Hashemi J, Azmi M, Rajabi T. Risk factors for hepatocellulr carcinoma in southern Iran. Saudi Med J 2005;26:974-77.
44. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis 2007;16:403-406.
45. Katanoda K, Yako-Suketomo H. Comparison of time trends in pancreatic cancer mortality (1990-2006) between countries based on the WHO mortality database. Jpn J Clin Oncol 2010;40:601-602.
46. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999;83:18-29.
47. Pourhoseingholi MA, Pourhoseingholi A, Vahedi M, Ashtari S, Safaee A, Moghimi-Dehkordi B, Zali MR. Pourhoseingholi. Decreased trend of pancreatic cancer mortality in Iran. Asian Pac J Cancer Prev 2011;12:153-55.
48. Taghavi A, Fazeli Z, Vahedi M, Baghestani AR, Zali MR, Pourhoseingholi MA. Pancreatic cancer mortality and misclassification--bayesian analysis. Asian Pac J Cancer Prev 2011;12:2271-74.
49. Pourhoseingholi MA, Zali MR. Colorectal cancer screening: Time for action in Iran. World J Gastrointest Oncol 2012;4:82-83.
50. Pourhoseingholi MA, Abadi A, Faghihzadeh S, Pourhoseingholi A, Vahedi M, Moghimi-Dehkordi B, Safaee A, Zali MR. Bayesian analysis of esophageal cancer mortality in the presence of misclassification. Ital J Public Health 2010; 8: 342-47.
51. Pourhoseingholi MA, Fazeli Z, Moghimi-Dehkordi B, Vahedi M, Pourhoseingholi A, Safaee A, et al. Increased oesophageal cancer mortality rate in Iran. Arab J Gastroenterol 2012; 13:82-84.